Evidence map›Paper›PMID 41495202›Full record

ArticleNature cell biology2026

The interpretable multimodal dimension reduction framework SpaHDmap enhances resolution in spatial transcriptomics.

Junjie Tang, Zihao Chen, Kun Qian, Siyuan Huang, Yang He, Shenyi Yin, Xinyu He, Buqing Ye, Yan Zhuang, Hongxue Meng and 2 more

Abstract read
In one paragraph

Article in Nature cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Junjie Tang *School of Mathematical Sciences and Center for Statistical Science, Peking University, Beijing, China.ORCID http://orcid.org/0009-0007-0612-2497
Zihao Chen *School of Mathematical Sciences and Center for Statistical Science, Peking University, Beijing, China.
Kun Qian *School of Mathematical Sciences and Center for Statistical Science, Peking University, Beijing, China.ORCID http://orcid.org/0000-0002-2354-2238
Siyuan HuangAcademy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
Yang HeState Key Laboratory of Natural and Biomimetic Drugs, Department of Biomedical Engineering, College of Future Technology, Peking University, Beijing, China.
Shenyi YinYangtze Center of Future Health Technology, Peking University, Beijing, China.
Xinyu HeState Key Laboratory of Natural and Biomimetic Drugs, Department of Biomedical Engineering, College of Future Technology, Peking University, Beijing, China.ORCID http://orcid.org/0000-0002-1913-9294
Buqing YeState Key Laboratory of Natural and Biomimetic Drugs, Department of Biomedical Engineering, College of Future Technology, Peking University, Beijing, China.
Yan ZhuangDepartment of Colorectal Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Hongxue MengDepartment of Pathology, Harbin Medical University Cancer Hospital, Harbin, China. menghongxue15@163.com.ORCID http://orcid.org/0000-0002-1831-2737
Jianzhong Jeff XiState Key Laboratory of Natural and Biomimetic Drugs, Department of Biomedical Engineering, College of Future Technology, Peking University, Beijing, China. jzxi@pku.edu.cn.ORCID http://orcid.org/0000-0003-3015-8418
Ruibin XiSchool of Mathematical Sciences and Center for Statistical Science, Peking University, Beijing, China. ruibinxi@math.pku.edu.cn.ORCID http://orcid.org/0000-0001-7545-7361

Funding

National Natural Science Foundation of China (National Science Foundation of China) 12371286National Natural Science Foundation of China (National Science Foundation of China) 12425110
6 · The paper itself

Abstract

Spatial transcriptomics (ST) technologies revolutionized tissue architecture studies by capturing gene expression with spatial context. However, high-dimensional ST data often have limited spatial resolution and exhibit considerable noise and sparsity, posing substantial challenges in deciphering subtle spatial structures and underlying biological activities. Here we introduce 'spatial high-definition embedding mapping' (SpaHDmap), an interpretable dimension reduction framework that enhances spatial resolution by integrating ST gene expression with high-resolution histology images. SpaHDmap incorporates non-negative matrix factorization into a deep learning framework, enabling the identification of high-resolution spatial metagenes (embeddings). Furthermore, SpaHDmap can simultaneously analyse multiple samples and is compatible with various types of histology images. Extensive evaluations on synthetic, public and newly sequenced ST datasets from various technologies and tissue types demonstrate that SpaHDmap can effectively produce high-resolution spatial metagenes, and detect refined spatial structures. SpaHDmap represents a powerful approach for integrating ST data and histology images, offering deeper insights into complex tissue structures and functions.

Indexed as

Gene Expression ProfilingTranscriptomeAnimalsComputational BiologyDeep LearningHumansMice

Identifiers

PMID41495202
PMCPMC12904794

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.